These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1581879)

  • 41. Morphologic and molecular cytogenetics in neuroblastoma.
    Avet-Loiseau H; Venuat AM; Benard J; Leibovitch MP; Hartmann O; Bernheim A
    Cancer; 1995 Apr; 75(7):1694-9. PubMed ID: 8826929
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeted expression of MYCN causes neuroblastoma in transgenic mice.
    Weiss WA; Aldape K; Mohapatra G; Feuerstein BG; Bishop JM
    EMBO J; 1997 Jun; 16(11):2985-95. PubMed ID: 9214616
    [TBL] [Abstract][Full Text] [Related]  

  • 43. N-myc amplification at chromosome band 1p32 in neuroblastoma cells as investigated by in situ hybridization.
    Longo L; Christiansen H; Christiansen NM; Cornaglia-Ferraris P; Lampert F
    J Cancer Res Clin Oncol; 1988; 114(6):636-40. PubMed ID: 3204111
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topology of double minutes (dmins) and homogeneously staining regions (HSRs) in nuclei of human neuroblastoma cell lines.
    Solovei I; Kienle D; Little G; Eils R; Savelyeva L; Schwab M; Jäger W; Cremer C; Cremer T
    Genes Chromosomes Cancer; 2000 Dec; 29(4):297-308. PubMed ID: 11066073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expulsion of amplified MYCN from homogenously staining chromosomal regions in neuroblastoma cell lines after cultivation with cisplatin, doxorubicin, hydroxyurea, and vincristine.
    Prochazka P; Hrabeta J; Vícha A; Eckschlager T
    Cancer Genet Cytogenet; 2010 Jan; 196(1):96-104. PubMed ID: 19963143
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of fluorescence in situ hybridization to detect N-myc (MYCN) gene amplification on paraffin-embedded tissue sections of neuroblastomas.
    Hachitanda Y; Saito M; Mori T; Hamazaki M
    Med Pediatr Oncol; 1997 Aug; 29(2):135-8. PubMed ID: 9180916
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of MYCN gene amplification in neuroblastoma by fluorescence in situ hybridization: a pediatric oncology group study.
    Mathew P; Valentine MB; Bowman LC; Rowe ST; Nash MB; Valentine VA; Cohn SL; Castleberry RP; Brodeur GM; Look AT
    Neoplasia; 2001; 3(2):105-9. PubMed ID: 11420745
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of MYCN amplification using blood plasma: noninvasive therapy evaluation and prediction of prognosis in neuroblastoma.
    Kojima M; Hiyama E; Fukuba I; Yamaoka E; Ueda Y; Onitake Y; Kurihara S; Sueda T
    Pediatr Surg Int; 2013 Nov; 29(11):1139-45. PubMed ID: 24022278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MYCN gene amplification. Identification of cell populations containing double minutes and homogeneously staining regions in neuroblastoma tumors.
    Yoshimoto M; Caminada De Toledo SR; Monteiro Caran EM; de Seixas MT; de Martino Lee ML; de Campos Vieira Abib S; Vianna SM; Schettini ST; Anderson Duffles Andrade J
    Am J Pathol; 1999 Nov; 155(5):1439-43. PubMed ID: 10550298
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations.
    Spitz R; Hero B; Westermann F; Ernestus K; Schwab M; Berthold F
    Genes Chromosomes Cancer; 2002 Jul; 34(3):299-305. PubMed ID: 12007190
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastoma.
    Spitz R; Hero B; Ernestus K; Berthold F
    Med Pediatr Oncol; 2003 Jul; 41(1):30-5. PubMed ID: 12764740
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N-myc amplification in multiple homogeneously staining regions in two human neuroblastomas.
    Emanuel BS; Balaban G; Boyd JP; Grossman A; Negishi M; Parmiter A; Glick MC
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3736-40. PubMed ID: 2582423
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation.
    Gross N; Beretta C; Peruisseau G; Jackson D; Simmons D; Beck D
    Cancer Res; 1994 Aug; 54(15):4238-42. PubMed ID: 7518353
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Automatic quantification of gene amplification in clinical samples by IQ-FISH.
    Narath R; Lörch T; Rudas M; Ambros PF
    Cytometry B Clin Cytom; 2004 Jan; 57(1):15-22. PubMed ID: 14696059
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MYCN is the only highly expressed gene from the core amplified domain in human neuroblastomas.
    Reiter JL; Brodeur GM
    Genes Chromosomes Cancer; 1998 Oct; 23(2):134-40. PubMed ID: 9739016
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heterogeneity of MYCN amplification in a child with stroma-rich neuroblastoma (ganglioneuroblastoma).
    Lorenzana AN; Zielenska M; Thorner P; Gerrie B; Weitzman S; Squire J
    Pediatr Pathol Lab Med; 1997; 17(6):875-83. PubMed ID: 9353827
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells.
    Spengler BA; Lazarova DL; Ross RA; Biedler JL
    Oncol Res; 1997; 9(9):467-76. PubMed ID: 9495452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sensitive and reliable detection of genomic imbalances in human neuroblastomas using comparative genomic hybridisation analysis.
    Van Gele M; Van Roy N; Jauch A; Laureys G; Benoit Y; Schelfhout V; De Potter CR; Brock P; Uyttebroeck A; Sciot R; Schuuring E; Versteeg R; Speleman F
    Eur J Cancer; 1997 Oct; 33(12):1979-82. PubMed ID: 9516837
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MYCN gene overrepresentation detected in primary neuroblastoma tumour cells without amplification.
    Valent A; Le Roux G; Barrois M; Terrier-Lacombe MJ; Valteau-Couanet D; Léon B; Spengler B; Lenoir G; Bénard J; Bernheim A
    J Pathol; 2002 Dec; 198(4):495-501. PubMed ID: 12434419
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alternative pathways of MYCN gene copy number increase in primary neuroblastoma tumors.
    Valent A; Guillaud-Bataille M; Farra C; Lozach F; Spengler B; Terrier-Lacombe MJ; Valteau-Couanet D; Danglot G; Lenoir GM; Brison O; Bénard J; Bernheim A
    Cancer Genet Cytogenet; 2004 Aug; 153(1):10-5. PubMed ID: 15325088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.